First AI vaccine trial results
A team of researchers tested the first vaccine entirely developed using artificial intelligence techniques to combat the coronavirus and its variants. Contrary to expectations, the initial results showed limited immune enhancement, with no strong antibody response observed in about 30 volunteers. However, the study was characterized by the absence of serious side effects, opening the door for larger clinical trials to explore this approach further in the development of more effective vaccines in the future.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)